Evidence map›Paper›PMID 21135126›Full record

ArticleMolecular and cellular biology2011

Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver.

Ritu Rana, Sailesh Surapureddi, Waynekid Kam, Stephen Ferguson, Joyce A Goldstein

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Med25 Limits Master Regulators That Govern Adipogenesis.International journal of molecular sciences · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Control of Muscle Metabolism by the Mediator Complex.Cold Spring Harbor perspectives in medicine · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ritu RanaLaboratory of Toxicology and Pharmacology, NIEHS, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Sailesh Surapureddi
Waynekid Kam
Stephen Ferguson
Joyce A Goldstein
National Institute of Environmental Health Sciences · USNational Institutes of Health · US

Funding

Gene Expression and MicroarraysZICES102445 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI GERRISH, KEVIN · 2009 to 2025
$31.6M
NIEHS NIH HHS Z01ES02124
6 · The paper itself

Abstract

Hepatocyte nuclear factor 4α (HNF4α) controls the expression of many critical metabolic pathways, and the Mediator complex occupies a central role in recruiting RNA polymerase II (Pol II) to these gene promoters. An impaired transcriptional HNF4α network in human liver is responsible for many pathological conditions, such as altered drug metabolism, fatty liver, and diabetes. Here, we report that Med25, an associated member of the Mediator complex, is required for the association of HNF4α with Mediator, its several cofactors, and RNA Pol II. Further, increases and decreases in endogenous Med25 levels are reflected in the composition of the transcriptional complex, Pol II recruitment, and the expression of HNF4α-bound target genes. A novel feature of Med25 is that it imparts "selectivity." Med25 affects only a significant subset of HNF4α target genes that selectively regulate drug and lipid metabolism. These results define a role for Med25 and the Mediator complex in the regulation of xenobiotic metabolism and lipid homeostasis.

Indexed as

Promoter Regions, GeneticCells, CulturedCytochrome P-450 Enzyme SystemDown-RegulationGene SilencingHEK293 CellsHepatocyte Nuclear Factor 4Hep G2 CellsHumansLipid MetabolismLiverMediator ComplexPharmaceutical PreparationsProtein BindingRNA Polymerase IISignal TransductionCytochrome P-450 Enzyme SystemHepatocyte Nuclear Factor 4MED25 protein, humanMediator ComplexPharmaceutical PreparationsRNA Polymerase IIXenobiotics

Identifiers

PMID21135126
PMCPMC3028616
OpenAlexW2160512307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.